Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Quarterly) : 31.71B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.71B |
| March 31, 2026 | 31.42B |
| December 31, 2025 | 31.26B |
| September 30, 2025 | 30.96B |
| June 30, 2025 | 29.94B |
| March 31, 2025 | 29.39B |
| December 31, 2024 | 29.35B |
| September 30, 2024 | 29.33B |
| June 30, 2024 | 28.21B |
| March 31, 2024 | 26.99B |
| December 31, 2023 | 25.97B |
| September 30, 2023 | 24.90B |
| June 30, 2023 | 24.02B |
| March 31, 2023 | 23.50B |
| December 31, 2022 | 22.66B |
| September 30, 2022 | 21.44B |
| June 30, 2022 | 20.69B |
| March 31, 2022 | 19.91B |
| December 31, 2021 | 18.77B |
| September 30, 2021 | 17.26B |
| June 30, 2021 | 15.13B |
| March 31, 2021 | 11.98B |
| December 31, 2020 | 11.03B |
| September 30, 2020 | 10.13B |
| June 30, 2020 | 9.057B |
| Date | Value |
|---|---|
| March 31, 2020 | 12.13B |
| December 31, 2019 | 11.09B |
| September 30, 2019 | 10.50B |
| June 30, 2019 | 9.756B |
| March 31, 2019 | 9.445B |
| December 31, 2018 | 8.757B |
| September 30, 2018 | 7.868B |
| June 30, 2018 | 7.186B |
| March 31, 2018 | 6.568B |
| December 31, 2017 | 6.144B |
| September 30, 2017 | 6.052B |
| June 30, 2017 | 5.521B |
| March 31, 2017 | 4.866B |
| December 31, 2016 | 4.449B |
| September 30, 2016 | 4.491B |
| June 30, 2016 | 4.077B |
| March 31, 2016 | 3.765B |
| December 31, 2015 | 3.655B |
| September 30, 2015 | 3.297B |
| June 30, 2015 | 3.338B |
| March 31, 2015 | 2.971B |
| December 31, 2014 | 2.542B |
| September 30, 2014 | 2.552B |
| June 30, 2014 | 2.369B |
| March 31, 2014 | 2.211B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Gilead Sciences, Inc. | 11.83B |
| AbbVie, Inc. | -5.935B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Amgen, Inc. | 11.69B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 41.73B |
| Total Liabilities (Quarterly) | 10.02B |
| Debt to Equity Ratio | 0.0854 |
| Current Ratio | 3.335 |
| Net Debt Paydown Yield | -0.00% |